CARB-X 2026 Funding Portal
Funding for innovators tackling Antimicrobial Resistance (AMR) in therapeutics and diagnostics.
- Funding amount
- Varies by program
- Funding type
- Equity
- Provider
- Centre for Cellular and Molecular Platforms (C-CAMP) (Incubator)
- Application deadline
- Closed (22 Apr 2024)
- Eligible stage
- Any stage
- Location
- Open to startups registered in India
Overview
The CARB-X 2026 Funding Portal invites innovators globally to submit Expressions of Interest for projects addressing Antimicrobial Resistance (AMR). CARB-X is a global public-private partnership accelerating the development of new antibacterial products and diagnostics to combat drug-resistant bacteria. As part of the CARB-X Global Accelerator Network, the Centre for Cellular and Molecular Platforms (C-CAMP) is the network's sole accelerator outside North America and Europe, uniquely positioned to identify and support breakthrough AMR innovations, especially those from India.
The program supports key product themes: direct-acting therapeutics targeting Gram-negative pathogens; target-based therapeutics under the CARB-X Novel Chemistry for AMR Challenge; non-vaccine approaches to prevent neonatal sepsis; and innovative diagnostics for early detection of neonatal sepsis. While specific funding amounts vary, selected projects receive significant financial support scaled to milestones. Beyond funding, C-CAMP offers non-monetary support including expert scientific and business guidance, access to a global network of leaders, and incubation support to accelerate translation from concept to clinical impact.
Highlights
- Open to global innovators, with strong support for Indian applicants through C-CAMP.
- Focus on AMR with specific product themes: Gram-negative pathogens, novel chemistry, neonatal sepsis prevention and diagnostics.
- Non-dilutive funding? Note: This is an equity program; CARB-X funding typically takes equity. Confirm whether this is equity or grants. The source says fundingType: 'equity'.
- Comprehensive non-monetary support including expert guidance, networking, and incubation.
- Two-stage application: Expression of Interest followed by detailed application for selected candidates.
Who can apply
The program is open to global applicants, including startups, academic research groups, and institutions with early-stage or preclinical projects focused on AMR. Researchers in infectious biology with a strong scientific foundation and a clear vision for novel antibacterial products or diagnostics are encouraged to apply. C-CAMP particularly welcomes applications from Indian innovators to bolster India's contribution to global AMR solutions. All proposals must align with the specified product themes: direct-acting therapeutics for Gram-negative pathogens, target-based therapeutics for the Novel Chemistry for AMR Challenge, non-vaccine approaches to prevent neonatal sepsis, and innovative diagnostics for neonatal sepsis.
CARB-X 2026 Funding Portal is open to startups at any stage. It is open to startups registered anywhere in India.
- Eligible stage
- Any stage
- Location
- Open to startups registered in India
Deadline & timing
The most recent application window for CARB-X 2026 Funding Portal closed on 22 Apr 2024. Many programmes run repeat cohorts, so it is worth checking the official site for the next round.
What the funding covers
- Financial support scaled to project needs and milestones, though specific amounts vary.
- Expert scientific and business guidance from C-CAMP's network.
- Access to a global network of scientific and industry leaders.
- Robust incubation support to accelerate product development.
- Opportunity to be part of the CARB-X Global Accelerator Network, enhancing visibility and collaboration opportunities.
About the provider
CARB-X 2026 Funding Portal is offered by Centre for Cellular and Molecular Platforms (C-CAMP), a startup incubator. It is delivered directly by Centre for Cellular and Molecular Platforms (C-CAMP) as a equity. You can verify current details and timelines on the provider's official website before applying.
How to apply
Applications are submitted on the official portal. Confirm the current deadline and document checklist there before you start.
Selection process
The application process begins with an Expression of Interest (EOI) submitted via the online portal. Applicants provide a concise overview of their project, scientific basis, proposed solution, and potential impact. This screening phase identifies the most promising innovations. Optional webinars are hosted to clarify guidelines and thematic focus. Successful EOI submissions are then invited to proceed with a more detailed application stage.
Documents you’ll need
Before you apply to CARB-X 2026 Funding Portal, keep the following documents ready:
- A pitch deck or short business plan describing the problem, product and traction
- Company registration documents and PAN
- Founder identification (PAN / Aadhaar) and brief profiles
- Recent financial statements or projections
- Product details — a demo, prototype or working link if available
Exact requirements are confirmed on the official application portal — treat this as a preparation checklist.
Frequently asked questions
What is the application deadline for CARB-X 2026 Funding Portal?
The deadline for submitting an Expression of Interest is 22 April 2024.
How much funding is available through CARB-X?
Specific funding amounts are not disclosed at the EOI stage, but selected projects receive significant financial support scaled to their needs and milestones.
Who is eligible to apply for this program?
The program is open to global innovators, including startups, academic research groups, and institutions with early-stage or preclinical projects addressing AMR. Indian innovators are especially encouraged.
What product themes are being funded?
The program seeks direct-acting therapeutics for Gram-negative pathogens, target-based therapeutics for the Novel Chemistry for AMR Challenge, non-vaccine approaches to prevent neonatal sepsis, and innovative diagnostics for neonatal sepsis.
Does CARB-X take equity from funded companies?
Yes, the funding type is listed as equity, meaning CARB-X may take a stake in the company in exchange for funding.
Do I need to be registered under DPIIT or MSME to apply?
No, DPIIT or MSME registration is not required for this program.
What documents are needed for the Expression of Interest?
You need to provide a concise overview of your project, including its scientific basis, proposed solution, and potential impact. Specific document requirements are outlined in the application portal.
How do I apply for the CARB-X 2026 Funding Portal?
Submit an Expression of Interest through the online portal at https://bit.ly/3P56UDB. Optional webinars are available to guide applicants.
What happens after I submit the Expression of Interest?
C-CAMP and CARB-X will review EOIs and invite promising projects to submit a more detailed application.
Is this program only for Indian companies?
No, it is open globally, but C-CAMP specifically supports Indian innovators.
Who offers CARB-X 2026 Funding Portal?
CARB-X 2026 Funding Portal is offered by Centre for Cellular and Molecular Platforms (C-CAMP), a startup incubator. It is provided as an investment.
More funding from Centre for Cellular and Molecular Platforms (C-CAMP)
Centre for Cellular and Molecular Platforms (C-CAMP) runs 5 other programs listed on startupfunds — compare them before you decide where to apply.
Alternatives to CARB-X 2026 Funding Portal
Not sure CARB-X 2026 Funding Portal is the right fit, or already applied? These are other equity open to Indian startups that founders shortlist alongside it.
Questions from founders
Ask anything about eligibility, documents or the process — answered by the community.
No questions yet — be the first to ask.